CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 58 filers reported holding CYCLERION THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $135,000 | -4.3% | 43,903 | +20.9% | 0.00% | – |
| Q2 2021 | $141,000 | +25.9% | 36,317 | -9.4% | 0.00% | – |
| Q1 2021 | $112,000 | 0.0% | 40,066 | +8.9% | 0.00% | – |
| Q4 2020 | $112,000 | +25.8% | 36,802 | +150.6% | 0.00% | – |
| Q3 2020 | $89,000 | -51.6% | 14,685 | -52.9% | 0.00% | – |
| Q2 2020 | $184,000 | +275.5% | 31,195 | +68.7% | 0.00% | – |
| Q1 2020 | $49,000 | -55.0% | 18,489 | -54.1% | 0.00% | – |
| Q4 2019 | $109,000 | -81.2% | 40,244 | -15.8% | 0.00% | – |
| Q3 2019 | $579,000 | -34.9% | 47,789 | -38.5% | 0.00% | – |
| Q2 2019 | $890,000 | – | 77,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $6,156,000 | 0.40% |
| MFN Partners Management, LP | 3,389,215 | $2,915,000 | 0.13% |
| Diametric Capital, LP | 243,711 | $210,000 | 0.11% |
| Artal Group S.A. | 2,779,122 | $2,391,000 | 0.10% |
| Intrinsic Value Partners, LLC | 48,315 | $42,000 | 0.06% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 292,645 | $252,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $99,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 92,541 | $80,000 | 0.00% |
| COLONY GROUP LLC | 102,884 | $88,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 231,952 | $198,000 | 0.00% |